Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

Tissue Renewal without Stem Cells

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Adult Stem Cells

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously renew...

Liver Regeneration

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clinical Pattern and Surgical Outcome of the Plexiform Neurofibromatosis Induced Ptosis.

Mymensingh medical journal : MMJ·2026

Same author

First Constraint on Atmospheric Millicharged Particles with the LUX-ZEPLIN Experiment.

Physical review letters·2025

Same author

New Constraints on Cosmic Ray-Boosted Dark Matter from the LUX-ZEPLIN Experiment.

Physical review letters·2025

Same author

Dark Matter Search Results from 4.2 Tonne-Years of Exposure of the LUX-ZEPLIN (LZ) Experiment.

Physical review letters·2025

Same author

Constraints on Covariant Dark-Matter-Nucleon Effective Field Theory Interactions from the First Science Run of the LUX-ZEPLIN Experiment.

Physical review letters·2024

Same author

First Dark Matter Search Results from the LUX-ZEPLIN (LZ) Experiment.

Physical review letters·2023

Search research articles

Related Experiment Video

Updated: Jun 7, 2026

Hepatic Progenitor Specification from Pluripotent Stem Cells using a Defined Differentiation System

Hepatic Progenitor Specification from Pluripotent Stem Cells using a Defined Differentiation System

Published on: May 10, 2020

An update on hepatic stem cells: bench to bedside.

N Parveen¹, A K Aleem, M A Habeeb

¹Centre For Liver Research and Diagnostics, Deccan College of Medical Sciences and Allied Hospitals, Owaisi Hospital and Research Centre, Kanchanbagh, Hyderabad, A.P, India.

Current Pharmaceutical Biotechnology

|November 4, 2010

Summary

This summary is machine-generated.

Liver transplantation is the only cure for liver failure, but donor scarcity and high costs are major hurdles. Hepatic progenitor cells offer a promising alternative due to their regenerative potential and resilience.

More Related Videos

Isolation and Enrichment of Liver Progenitor Subsets Identified by a Novel Surface Marker Combination

Isolation and Enrichment of Liver Progenitor Subsets Identified by a Novel Surface Marker Combination

Published on: February 18, 2017

Application of Live Mitochondria Staining in Cell-Sorting to Purify Hepatocytes Derived from Human Induced Pluripotent Stem Cells

Application of Live Mitochondria Staining in Cell-Sorting to Purify Hepatocytes Derived from Human Induced Pluripotent Stem Cells

Published on: December 1, 2023

Related Experiment Videos

Last Updated: Jun 7, 2026

Hepatic Progenitor Specification from Pluripotent Stem Cells using a Defined Differentiation System

Hepatic Progenitor Specification from Pluripotent Stem Cells using a Defined Differentiation System

Published on: May 10, 2020

Isolation and Enrichment of Liver Progenitor Subsets Identified by a Novel Surface Marker Combination

Isolation and Enrichment of Liver Progenitor Subsets Identified by a Novel Surface Marker Combination

Published on: February 18, 2017

Application of Live Mitochondria Staining in Cell-Sorting to Purify Hepatocytes Derived from Human Induced Pluripotent Stem Cells

Application of Live Mitochondria Staining in Cell-Sorting to Purify Hepatocytes Derived from Human Induced Pluripotent Stem Cells

Published on: December 1, 2023

Area of Science:

Hepatology
Regenerative Medicine
Transplantation Biology

Background:

Liver failure affects multiple organs and has a high mortality rate, with liver transplantation being the primary treatment.
Orthotopic liver transplantation (OLTx) faces challenges including donor organ shortage, high treatment costs, surgical risks, and post-transplant rejection.
Current cell-based therapies like hepatocyte transplantation have limitations, including poor proliferation and viability.

Purpose of the Study:

To explore hepatic progenitor cells as a potential alternative to whole liver transplantation.
To highlight the advantages of hepatic progenitor cells over mature hepatocytes for cell-based therapies.
To discuss sources and properties of hepatic progenitor cells relevant for liver regeneration.

Main Methods:

Review of studies on hepatic progenitor cell isolation and characterization.
Comparison of hepatic progenitor cell properties with mature hepatocytes.
Investigation of potential sources for hepatic progenitor cells, including fetal and bone marrow-derived cells.

Main Results:

Hepatic progenitor cells exhibit superior proliferative capacity compared to mature hepatocytes.
These progenitor cells demonstrate enhanced resistance to cryopreservation and ischemic injury.
Fetal cells and autologous bone marrow stem cells show promise as sources for hepatic progenitor cells.

Conclusions:

Hepatic progenitor cells present a viable alternative or bridge therapy for liver failure, overcoming limitations of current treatments.
Their inherent properties facilitate better engraftment and potential for liver regeneration.
Further research into hepatic progenitor cell therapies could significantly improve outcomes for patients with chronic liver disease.